Amit Bhalla - 28 Feb 2022 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Erika L. Eves for Amit Bhalla, by power of attorney
Issuer symbol
N/A
Transactions as of
28 Feb 2022
Net transactions value
$0
Form type
4
Filing time
01 Mar 2022, 15:04:47 UTC
Previous filing
01 Feb 2022
Next filing
31 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $0 +2,500 +5.2% $0.000000 50,568 28 Feb 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.
F2 Issuance deferred at the request of the Reporting Person.